Skip to main content

2022-01-14: Advances in the Management of Diabetes 2022 (Credit)

Tracking # 20-978464

$119.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

At the conclusion of this program, the participant will be able to: 1. Review recent updates to the standards of care recommended by the American Diabetes Association. 2. . Describe recent cardiovascular and renal outcome trials for new diabetes medications and their implications for patient care. 3. Develop a plan to safely initiate and intensify insulin therapy using guideline recommendations and patient characteristics. 4. Evaluate the use of continuous glucose monitoring (CGM) devices in the management of diabetes. 5. Optimize pharmacotherapy for a patient with diabetes using glucose data.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Midwife

5h Pharmacotherapeutics continuing education in the area of certification

Certified Nurse Practitioner

5h Pharmacotherapeutics continuing education in the area of certification

Certified Registered Nurse Anesthetist

5h Pharmacotherapeutics continuing education in the area of certification

Clinical Nurse Specialist

5h Pharmacotherapeutics continuing education in the area of certification

Licensed Practical Nurse

5h Practice-Focused Continuing Education

Licensed Psychiatric Technician Nurse

5h Practice-Focused Continuing Education

Registered Nurse

5h Practice-Focused Continuing Education

Registered Nurse Practitioner

5h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Certified Nurse Midwife

5h Pharmacology Component

Clinical Nurse Specialist

5h Pharmacology Component

Licensed Practical Nurse

5h Licensed Practical Nurse - Continuing Education

Nurse Practitioner

5h Pharmacology Component

Registered Nurse

5h Registered Nurse District of Columbia - Continuing Education

Registered Nurse Anesthetist

5h Pharmacology Component

Florida Board of Pharmacy

Pharmacist

5h General

Registered Pharmacy Technician

5h General

Florida Physician Assistants

Physician Assistant

5h General (Category II)

Georgia Board of Nursing

Licensed Practical Nurse

5h General

Registered Professional Nurse

5h General

New Mexico Board of Nursing

Certified Nurse Practitioner

5h Continuing education related to pharmacology

Certified Registered Nurse Anesthetist

5h Continuing education related to pharmacology

Clinical Nurse Specialist

5h Continuing education related to pharmacology

Licensed Practical Nurse

5h Continuing education relevant to the licensed practical nurse

Registered Nurse

5h Continuing education relevant to nursing practice

North Dakota Board of Nursing

Licensed Practical Nurse

5h CE Related to Nursing Practice

Registered Nurse

5h Pharmacotherapy Related to Scope of Practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

5h Pharmacotherapeutics

Licensed Practical Nurse

5h Pharmacotherapeutics

Registered Nurse

5h Pharmacotherapeutics

West Virginia Board of Registered Nurses

Advanced Practice Registered Nurse

5h Prescriptive Authority Privilege (RXA) pharmacotherapeutic

Registered Nurse

5h Prescriptive Authority Privilege (RXA) pharmacotherapeutic

Disclosure statements

Dr. Trujillo is a consultant to Sanofi and served on advisory board for BD Pharmaceuticals